About 100 reports

  • 5.9 UNITED KINGDOM - INFLUENZA VACCINES MARKET, PERSONS VACCINATED
  • 5.15 AUSTRALIA - INFLUENZA VACCINES MARKET, PERSONS VACCINATED AND
  • Influenza
  • Europe
  • Forecast
  • Market Size
  • Sanofi S.A.
  • Influenza Drugs
  • UK Influenza Therapeutics Market
  • Influenza
  • World
  • Market Size
  • Emergent BioSolutions Inc.
  • Sanofi S.A.
  • 4.2 CANADA - INFLUENZA VACCINES MARKET, PERSONS VACCINATED AND
  • 4.1 UNITED STATES - INFLUENZA VACCINES MARKET, PERSONS VACCINATED AND
  • Influenza
  • GlaxoSmithKline plc
  • MedImmune, LLC
  • Novartis AG
  • Sanofi S.A.
  • 4.22.1 Singapore - Number of Persons Vaccinated with Influenza Vaccines and
  • 4.5 GERMANY - INFLUENZA VACCINES MARKET, PERSONS VACCINATED AND
  • Influenza
  • Europe
  • Forecast
  • Market Size
  • Sanofi S.A.
  • 4.2 CHINA - INFLUENZA VACCINES MARKET, PERSONS VACCINATED AND
  • 2.2 ASIA AND AUSTRALASIA - NUMBER OF PERSONS VACCINATED WITH INFLUENZA
  • Influenza
  • Asia
  • Market Size
  • Novartis AG
  • Sanofi S.A.
  • TYPES OF INFLUENZA
  • SYMPTOMS OF INFLUENZA
  • Influenza
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Novartis AG
  • Sanofi S.A.
  • RIDTS FOR INFLUENZA A
  • RIDTS FOR INFLUENZA B
  • Influenza
  • World
  • Forecast
  • Alere Inc.
  • Quidel Corporation
  • INFLUENZA SYMPTOMS
  • NOTABLE INFLUENZA PANDEMICS
  • Influenza
  • Europe
  • CSL Limited
  • Daiichi Sankyo Company
  • Mitsubishi Corporation
  • 3. Structure of Influenza Virus
  • 4. Notable Influenza Pandemics
  • Influenza
  • Vaccine
  • Europe
  • Forecast
  • Market Size
  • 7.5 INCREASING AWARENESS ON SEASONAL INFLUENZA & VACCINATION
  • 4.1 GERMANY - INFLUENZA VACCINES MARKET, PERSONS VACCINATED AND
  • Influenza
  • Europe
  • Market Size
  • Novartis AG
  • Sanofi S.A.
  • INFLUENZA (AGE 18 YEARS AND OLDER)
  • Focus on advancing its clinical trials associated with influenza Simplifying operational model to increase efficiency
  • Influenza
  • Market Size
  • AstraZeneca PLC
  • Novartis AG
  • Sanofi S.A.
  • Symptoms of Influenza
  • Available Antiviral Drugs for Seasonal Influenza
  • Influenza
  • Asia
  • World
  • Daiichi Sankyo Company
  • Sanofi S.A.
  • Notable Influenza Pandemics
  • 2. Influenza - Introduction
  • Influenza
  • Vaccine
  • Europe
  • Forecast
  • Market Size
  • Seasonal Influenza Vaccinated Population
  • Seasonal Influenza Vaccine Market
  • Influenza
  • Vaccine
  • Europe
  • Forecast
  • Market Size
  • Seasonal Influenza Vaccinated Population
  • Seasonal Influenza Vaccine Market
  • Influenza
  • Vaccine
  • Europe
  • Forecast
  • Market Size
  • Seasonal Influenza Vaccinated Population
  • Seasonal Influenza Vaccine Market
  • Influenza
  • Vaccine
  • Europe
  • Forecast
  • Market Size
  • Seasonal Influenza Vaccine Market
  • Seasonal Influenza Vaccinated Population
  • Influenza
  • Vaccine
  • Europe
  • Forecast
  • Market Size
  • Seasonal Influenza Vaccinated Population
  • Seasonal Influenza Vaccine Market
  • Influenza
  • Estonia
  • Europe
  • Latvia
  • Lithuania

2025 ## Table ##: Key Launch Dates ## Table ##: High-Prescribing Physicians (non-KOLs) Surveyed, By Country ## ##. ## List of Figures Figure ##: Influenza Virus Structure ## Figure ##: Seasonal Influenza Vaccines - Phase II/ Phase III Pipeline, 2016 ## Figure ##: Competitive Ass

  • Influenza
  • Therapy
  • Vaccine
  • World
  • Demand

2025 ## Table ##: Key Launch Dates ## Table ##: High-Prescribing Physicians (non-KOLs) Surveyed, By Country ## ##. ## List of Figures Figure ##: Influenza Virus Structure ## Figure ##: Seasonal Influenza Vaccines - Phase II/ Phase III Pipeline, 2016 ## Figure ##: Competitive Ass

  • Influenza
  • Therapy
  • Vaccine
  • World
  • Demand
  • Cold and Flu Drugs Sales Volume by Price
  • Cold and Flu Drugs Sales Volume by Drugs
  • Influenza
  • China
  • Demand
  • Trade
  • Sanshine Pharmaceutical Co., Ltd.
  • Cold and Flu Drugs Sales Volume
  • of China's Cold and Flu Drugs industry sales
  • Influenza
  • China
  • Sanshine Pharmaceutical Co., Ltd.
  • Tongrentang Group
  • Topsun Technology Qidong Gantianli Pharmaceutical Co., Ltd

INFLUENZA SEASONS, 2003-2017 ## TABLE ## THIMEROSAL CONTENT OF INFLUENZA VACCINES (U. S.

  • Influenza
  • Pathology
  • Therapy
  • Vaccine
  • World
  • INFLUENZA A
  • Types of human influenza viruses
  • In Vitro Diagnostics
  • Influenza
  • Alere Inc.
  • bioMerieux S.A.
  • Quidel Corporation
  • 2.3.2 Laboratory Confirmed Influenza Cases
  • Risk Factors and Comorbidities for Seasonal Influenza
  • Influenza
  • Vaccine
  • Germany
  • Japan
  • Forecast
  • GLOBAL INFLUENZA THERAPEUTICS MARKET
  • GLOBAL INFLUENZA THERAPEUTICS MARKET 2016-2021 ($ BILLIONS)
  • Influenza
  • World
  • Bristol-Myers Squibb Company
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • TECHNOVAX, INC. - DORMANT DEVELOPMENTAL PROJECTS,2015
  • TECHNOVAX, INC. - PIPELINE BY INDICATION, 2015
  • Influenza
  • World
  • Supply
  • Pfizer Inc.
  • TechnoVax Inc.
  • Cold and Flu Drugs Sales Volume
  • of China's Cold and Flu Drugs industry sales
  • Influenza
  • China
  • Guangzhou Baiyunshan Pharmaceutical Co., Ltd.
  • Tongrentang Group
  • Topsun Technology Qidong Gantianli Pharmaceutical Co., Ltd
  • Previous Flu Seasons in the United States
  • Americans' attitudes towards the flu vaccination
  • Cough Cold
  • Influenza
  • United States
  • Demand
  • Mondelez International, Inc.

Influenza vaccines

4546 5000 3864
  • FORECAST: SEASONAL INFLUENZA VACCINES
  • PIPELINE: SEASONAL INFLUENZA VACCINES
  • Influenza
  • Europe
  • Forecast
  • Novavax, Inc.
  • Sanofi S.A.